Introduction
============

Liver transplantation is the most effective therapeutic strategies for end-stage liver diseases; however, the ever-increasing shortage of donor organs limits the development of liver transplantation and leads to the use of livers from expanded criteria donors (ECDs) ([@b1-mmr-22-03-2003]). As a result, marginal organs that are more susceptible to the harmful effects of ischemia-reperfusion injury (IRI) are frequently used for transplantation ([@b2-mmr-22-03-2003]). IRI is a complicated pathophysiological process that is difficult to avoid during liver transplantation. Multiple mechanisms contribute to the process of IRI, of which inflammation and oxidative stress display major roles ([@b3-mmr-22-03-2003],[@b4-mmr-22-03-2003]). After transplantation, patients who receive marginal organs are more likely to develop early allograft dysfunction, liver rejection and biliary complications, and thus have a higher risk of unfavorable short- and long-term outcomes ([@b5-mmr-22-03-2003]). Therefore, the effective maintenance and optimization of the quality of organs donated after circulatory death (DCD) are urgent problems in the field of organ transplantation.

In order to attenuate IRI, the organ preservation method of HMP has received increasing interest worldwide ([@b6-mmr-22-03-2003],[@b7-mmr-22-03-2003]). The first clinical study on liver HMP confirmed its effectiveness for DCD and ECD organs, with HMP displaying improved results compared with cold storage (CS) ([@b8-mmr-22-03-2003]). Previous studies investigating the application of HMP for discarded human livers verified the advantages of the technique ([@b7-mmr-22-03-2003],[@b9-mmr-22-03-2003]). Furthermore, the protective effects of HMP in DCD organs has been reported. In a previous study, HMP was employed for 1--7 h and displayed beneficial outcomes for all durations ([@b10-mmr-22-03-2003]). However, the optimal duration of HMP to reduce liver injury and maintain optimal liver viability, as well as the exact molecular mechanisms underlying HMP-mediated protection of DCD livers, have not been previously reported.

Lüer *et al* ([@b11-mmr-22-03-2003]) reported that HMP can upregulate kruppel-like factor 2 (KLF2) expression in livers. KLF2 is a transcriptional regulator that has a zinc-finger structure and is highly expressed in the lungs and vascular endothelium. KLF2 expression can be induced by laminar sheer stress, resulting in atheroprotective, anticoagulant and anti-inflammatory effects ([@b12-mmr-22-03-2003],[@b13-mmr-22-03-2003]). Several studies have demonstrated that KLF2 can inhibit the transcriptional activity of NF-κB, which controls the transcription and expression of various cytokines and adhesion molecules involved in inflammation and the immune response. For example, NF-κB can reduce the expression of tumor necrosis factor (TNF)-α and interleukin (IL)-1β to attenuate inflammation ([@b14-mmr-22-03-2003]--[@b20-mmr-22-03-2003]). Wang *et al* ([@b21-mmr-22-03-2003]) demonstrated that flow-stimulated phosphorylation and nuclear export of histone deacetylase 5 (HDAC5) results in the dissociation of HDAC5 and myocyte enhancer factor 2C (MEF2C), which enhances the transcriptional activity of MEF2C and induces the expression of KLF2 and endothelial nitric oxide synthase (eNOS), increasing nitric oxide (NO) levels in human umbilical vein endothelial cells (ECs) exposed to laminar flow. eNOS is a Ca^2+^-, NADPH-, flavin- and biopterin-dependent enzyme that can constitutively produce NO in various cells. The activity of eNOS is tightly regulated by different mechanisms, of which phosphorylation at specific amino acids can lead to activation or inhibition of eNOS activity depending on the localization in the protein sequence ([@b22-mmr-22-03-2003],[@b23-mmr-22-03-2003]). Among the numerous phosphorylation sites, Ser1177 is rapidly phosphorylated after the application of fluid shear stress, which results in eNOS activation to sustain moderate NO generation ([@b24-mmr-22-03-2003]). NO displays important biological functions, including vasodilatation, scavenging of superoxide, inhibition of platelet aggregation, and reduction of proliferation and inflammation ([@b22-mmr-22-03-2003]--[@b25-mmr-22-03-2003]). However, only a limited number of studies have investigated the anti-inflammatory and antioxidant effects of the KLF2/NF-κB/eNOS/NO signaling pathway during organ transplantation.

Although HMP has been widely researched, the optimal duration of HMP to effectively attenuate IRI has not been previously reported and the molecular mechanisms underlying the protective effects of HMP are not completely understood. The present study aimed to investigate the optimal duration of liver HMP by comparing anti-inflammatory and antioxidant activities during IRI. In addition, whether the protective effects of HMP were exerted via the KLF2/NF-κB/eNOS/NO signaling was investigated.

Materials and methods
=====================

### Animals

A total of 42 adult male Sprague Dawley (SD) rats (age, 8--10 weeks; weight, 250--300 g) were purchased from the Experimental Animal Culture Center of the Hubei Center for Disease Control. All animals received standard care and were housed under standard laboratory conditions (temperature, 25±2°C; relative humidity, 55±5%; a 12 h light/dark cycle) in Zhongnan Hospital\'s Animal Experiment Center of Wuhan University. Animals had free access to food and water. The present study was approved by the Ethical Committee of Wuhan University and carried out in accordance with the Experimental Animal Management Ordinance (National Science and Technology Committee of China) and the Guide for the Care and Use of Laboratory Animals (National Institutes of Health) ([@b26-mmr-22-03-2003]).

### Establishment of the rat model of DCD

Rats were anesthetized by the intraperitoneal injection of pentobarbital sodium (50 mg/kg). An abdominal longitudinal incision was made, and the hepatic artery, portal vein, supra- and infrahepatic inferior vena cava, bile duct and peripheral ligaments were freed to fully expose the liver. An epidural guiding conduit was inserted (Jiangsu Changfeng Medical Industry Co., Ltd.) into the bile duct. After ligation of the left phrenic vein, the diaphragm was cut to induce bilateral pneumothorax and cardiac arrest. The period of WI started from the point of cardiac arrest ([@b27-mmr-22-03-2003]). After 30 min of WI, systemic heparinization was implemented by the injection of 2 ml Ringer (Chimin Health Management Co., Ltd.; [www.chimin.cn](www.chimin.cn)) and 100 IU heparin (Hepatunn; <http://www.hepatunn.com/>) via the right iliac vein ([@b28-mmr-22-03-2003]). Subsequently, the hepatic artery was ligated and the liver was flushed *in situ* with 20 ml 0--4°C Histidine Tryptophan Ketoglutarate (HTK) solution (Dr Franz Koehler Chemie GmbH) via the portal vein intubation \[homemade pressure equalizer (PE) tubes; outer diameter, 2.1 mm; inner diameter, 1.8 mm\]. To collect the hepatic effluent, the suprahepatic inferior vena cava was intubated using a PE catheter (inner diameter, 3 mm) ([@b29-mmr-22-03-2003]).

### Preservation of DCD livers

SD rats were randomly divided into the HMP group and the CS group. In the HMP group (n=18), the livers were obtained after 30 min of WI and 0--4°C HTK solution (150 ml) was perfused via the portal vein for 0, 1, 3, 5, 12 or 24 h at a rate of 0.5 ml/g/min ([@b29-mmr-22-03-2003]). At each time point, three livers were harvested. In the CS group (n=18), after 30 min of WI, the livers were maintained in CS (0-4°C) in HTK solution (150 ml) for 0, 1, 3, 5, 12 or 24 h. At each time point, three livers were harvested. The WI group consisted of livers harvested at 0 h in both groups.

### Evaluation of preservation effects

SD rats were randomly divided into the HMP + normothermic reperfusion (NR) group and the CS + NR group. In the HMP + NR group (n=3), HMP was performed for 3 h followed by NR for 2 h using the isolated perfused rat liver (IPRL) system. In the CS + NR group (n=3), livers were maintained in CS for 3 h followed by NR for 2 h using the IPRL system.

### Liver perfusion system

A thermostat water bath (Jiaxingjunsi Electronics Co., Ltd.) containing a liver perfusion box was used. The temperature of the bath was controlled by heated water around the box or by an ice-water mixture inside the box. The temperature of the liver perfusion box was monitored using a temperature sensor (Xinghe Electronics Co., Ltd.). A peristaltic pump (Longerpump Technologies Inc.; <http://www.longerpump.com/>), a hollow-fiber membrane oxygenator (Dongguan Kewei Medical Instrument Co., Ltd.) and a flow meter (Hehua Mechanical and Electric Corporation; <http://hqn640901.d17.cc/>) were connected to complete the perfusion system. The portal vein cannula was connected to the baroreceptor of a BL-420F Biological Functional System (Chengdu Taimeng Science and Technology Co., Ltd.; <http://www.tme.com.cn/>) to measure the portal perfusion pressure.

### IPRL system

After HMP or CS, livers were rewarmed for 20 min to simulate the period of rewarming during transplantation. Subsequently, the liver was connected to the IPRL system, which consists of a liver perfusion system with an oxygen supply. The temperature of the water bath was set to 40°C to maintain the temperature of the liver container at 36.5±0.5°C. Krebs-Henseleit buffer (Macgene; <http://www.macgene.com/>) with 4% dextran (Xian Wanlong Pharmaceutical Co., Ltd.; <http://www.xawanlong.com/>) was used for reperfusion ([@b30-mmr-22-03-2003]). The perfusate was oxygenated with 95% O~2~ + 5% CO~2~ gas to maintain \>500 mmHg oxygen pressure. During the 2 h perfusion, the portal vein perfusion pressure was maintained at 10.3 mmHg ([@b10-mmr-22-03-2003],[@b31-mmr-22-03-2003]).

### Biochemical examination

During the 2 h reperfusion, alanine transaminase (ALT; cat. no. C009; Nanjing Jiancheng Bioengineering Institute), aspartate transaminase (AST; cat. no. C010; Nanjing Jiancheng Bioengineering Institute) and lactate dehydrogenase (LDH; cat. no. A020; Nanjing Jiancheng Bioengineering Institute) levels were measured in the hepatic effluent that was collected from the suprahepatic vena cava every 60 min using commercial standard kits, according to the manufacturer\'s protocol.

### Oxygen consumption

To assess the metabolic activity of the livers, hepatic oxygen consumption was analyzed every 60 min during the 2 h reperfusion using an i-STAT pH-blood gas analyzer (Abbott Point of Care, Inc.). Oxygen consumption (μmol/min/g liver) was calculated according to the following formula: (C~in~ - C~out~) / portal flow (ml/min) / liver weight (g), where C~in~ and C~out~ represent the oxygen concentration of the liver inflow and outflow, respectively ([@b31-mmr-22-03-2003]).

### Bile production

Bile was collected every 60 min via the epidural guiding tube that was positioned in the bile duct. Bile flow is expressed as µl/h/g liver, as the density of bile is almost equal to that of water ([@b10-mmr-22-03-2003]).

### Liver histology

Liver samples were stored in 10% formaldehyde at room temperature for 1--5 days, embedded in paraffin, and cut into 3-µm sections. Subsequently, sections were stained with hematoxylin and eosin (HE) at room temperature (hematoxylin staining for 5--10 min and eosin staining for 1--3 min). The severity of hepatic injury was assessed by pathologists who were blinded to the experiment using a light microscope at ×200 magnification according to the classification described by Suzuki *et al* ([@b32-mmr-22-03-2003]). Breifly, sinusoidal congestion, hepatocyte necrosis and ballooning degeneration were graded from 0 to 4, where 0 indicated no necrosis, congestion or ballooning, and 4 indicated severe congestion, ballooning degeneration or hepatocyte necrosis (\>60%).

### Western blotting

Total protein was extracted from liver tissues using RIPA lysis buffer (Beyotime Institue of Biotechnology; cat. no. P0013B) containing protease inhibitor and quantified by the bicinchoninic acid method. Protein (40 µg/lane) was separated via 10% SDS-PAGE and transferred onto PVDF membranes, which were blocked with 5% skim milk (cat. no. G5002; Wuhan Servicebio Technology Co., Ltd.) at room temperature for 2 h. Subsequently, the membranes were incubated overnight at 4°C with the following primary antibodies: anti-MEF2C (rabbit; 1:500; cat. no. 10056-1-AP; ProteinTech Group, Inc.), anti-KLF2 (rabbit; 1:400; cat. no. bs-2772R; Beijing Biosynthesis Biotechnology Co., Ltd.), anti-NF-κB p65 (rabbit; 1:400; cat. no. bs-20355R; Beijing Biosynthesis Biotechnology Co., Ltd.), anti-eNOS (rabbit; 1:1,000; cat. no. 20116-1-AP; ProteinTech Group, Inc.), anti-phosphorylated eNOS at Ser1177 (rabbit; 1:1,000; cat. no. 9571, Cell Signaling Technology, Inc.) and anti-β-actin (rabbit; 1:1500; cat. no. bs-0061R; Beijing Biosynthesis Biotechnology Co., Ltd.). After washing with TBST (Tris, 2.42 g; NaCl, 8 g; Tween, 1 ml; Distilled Water, 1,000 ml), the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (H+L) antibodies (1:3,000; cat. no. G1213; Wuhan Servicebio Technology Co., Ltd.) at room temperature for 2 h. Protein bands were visualized using chemiluminescence ECL reagent (cat. no. AR1172; Boster Biological Technology). Protein expression was quantified using ImageJ software (version 1.42q; National Institutes of Health) with β-actin as the loading control.

### ELISA

TNF-α (cat. no. ERC102a; QuantiCyto, <http://www.neobioscience.net/pro_view-7421.html>) and IL-1β (cat. no. ERC007; QuantiCyto; [http://www.neobioscience.net/ pro_view-7346.html](http://www.neobioscience.net/ pro_view-7346.html)) expression levels in liver tissues and NO levels (cat. no. A012; Nanjing Jiancheng Bioengineering Institute) in the perfusate were measured using ELISA kits.

### Statistical analysis

Statistical analyses were performed using SPSS software (version 17.0; SPSS, Inc.). Data are presented as the mean ± standard error. The normality of each results was analyzed by homogeneity of variance analysis. Differences between two groups were analyzed using the unpaired Student\'s t-test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### HMP attenuates WI-induced pathological liver injury

First, hepatic pathological injury was assessed ([Fig. 1](#f1-mmr-22-03-2003){ref-type="fig"}). Injury was quantified using a previously validated liver pathological damage scoring system ([@b32-mmr-22-03-2003]), where a higher score indicated greater damage. After 30 min of WI, livers displayed significant sinusoidal congestion, hepatocyte edema, anoxic vacuoles, dot necrosis and high numbers of lymphocytes. In the livers of the CS group, severe hepatocellular swelling/necrosis, sinusoidal congestion and inflammatory cell infiltration was observed. The livers of the HMP group displayed less damage compared with the CS group ([Fig. 1A](#f1-mmr-22-03-2003){ref-type="fig"}). Moreover, the HMP group displayed a significantly lower pathology score compared with the CS group at 3, 5, 12 and 24 h (P\<0.05), with the lowest score recorded at the 3 h timepoint. At the 1 h timepoint, the difference in pathology score was not significant between the HMP and CS groups (P\>0.05; [Fig. 1B](#f1-mmr-22-03-2003){ref-type="fig"}). The results suggested that HMP preserved DCD livers more effectively compared with CS.

### HMP increases MEF2C and KLF2 expression and decreases NF-κB p65, TNF-α and IL-1β expression during the ischemic phase

Subsequently, the protein expression levels of MEF2C, KLF2 and NF-κB p65 were assessed by western blotting to determine the effects of HMP on hepatic inflammation ([Fig. 2](#f2-mmr-22-03-2003){ref-type="fig"}). MEF2C and KLF2 expression levels were significantly increased in the HMP group compared with the CS group at 3, 5, 12 and 24 h (P\<0.05; [Fig. 2B and C](#f2-mmr-22-03-2003){ref-type="fig"}). By contrast, the expression levels of NF-κB p65 were significantly lower in the HMP group compared with the CS group at 3, 5, 12 and 24 h (P\<0.05; [Fig. 2D](#f2-mmr-22-03-2003){ref-type="fig"}). TNF-α and IL-1β are downstream genes of NF-κB p65 ([@b33-mmr-22-03-2003]); therefore, the expression of the two inflammatory cytokines was measured by ELISA to assess the degree of NF-κB p65-induced inflammation. TNF-α and IL-1β levels were significantly lower in the HMP group compared with the CS group at 3, 5, 12 and 24 h (P\<0.05; [Fig. 2E and F](#f2-mmr-22-03-2003){ref-type="fig"}). For all genes, the most notable difference between the HMP group and the CS group was observed at the 3 h timepoint. However, the expression levels of the examined genes were not significantly different between the HMP and CS groups at the 1 h timepoint (P\>0.05).

### HMP alleviates reperfusion-induced hepatocellular injury

The protective effects of HMP were further assessed using the IPRL system, which can imitate the physical environment. The release of ALT, AST and LDH during reperfusion was measured. ALT, AST and LDH concentrations sharply increased following reperfusion in both the HMP and CS groups ([Fig. 3](#f3-mmr-22-03-2003){ref-type="fig"}). However, enzyme levels were significantly lower in the HMP group compared with the CS group at 60 and 120 min (P\<0.05; [Fig. 3A-C](#f3-mmr-22-03-2003){ref-type="fig"}). Livers in the HMP group displayed significantly higher rates of oxygen consumption compared with the CS group at 0, 60 and 120 min (P\<0.05; [Fig. 3D](#f3-mmr-22-03-2003){ref-type="fig"}). In addition, bile production was slightly higher in the HMP group compared with the CS group, but the difference was not statistically significant at 120 min (P\>0.05; [Fig. 3E](#f3-mmr-22-03-2003){ref-type="fig"}).

### HMP increases MEF2C and KLF2 expression and decreases NF-κB p65, IL-1β and TNF-α expression during the reperfusion phase

Based on the observation that HMP for 3 h increased MEF2C and KLF2 expression and decreased NF-κB p65, TNF-α and IL-1β expression ([Fig. 2](#f2-mmr-22-03-2003){ref-type="fig"}), the protective mechanisms underlying HMP were further investigated by evaluating protein expression after NR. MEF2C and KLF2 expression levels were significantly increased in livers of the HMP + NR group compared with the CS + NR group (P\<0.05; [Fig. 4A-C](#f4-mmr-22-03-2003){ref-type="fig"}). By contrast, NF-κB p65, TNF-α and IL-1β expression levels were significantly decreased in the HMP + NR group compared with the CS + NR group (P\<0.05; [Fig. 4D-F](#f4-mmr-22-03-2003){ref-type="fig"}). The results indicated that HMP may attenuate IRI-induced hepatic inflammation.

### HMP increases eNOS and NO levels during the reperfusion phase

Finally, whether HMP could reduce IRI-associated oxidative stress was assessed by evaluating the expression of eNOS and p-eNOS at Ser1177. In livers preserved by HMP, significantly higher levels of eNOS and p-eNOS were observed compared with livers preserved by CS, and the ratio of p-eNOS/eNOS was also significantly increased(P\<0.05; [Fig. 5A-D](#f5-mmr-22-03-2003){ref-type="fig"}). eNOS constitutively produces NO; therefore, NO levels in the perfusate after 2 h of NR were also measured by ELISA. NO levels were significantly higher in the HMP group compared with the CS group (P\<0.05; [Fig. 5E](#f5-mmr-22-03-2003){ref-type="fig"}). Therefore, the results indicated that HMP reduced hepatic oxidative stress during IRI.

Discussion
==========

The increased demand for organs has led to the use of ECD and DCD organs, which often require longer periods of WI or cold ischemia, resulting in a higher risk of serious injury and unfavorable outcomes ([@b2-mmr-22-03-2003],[@b6-mmr-22-03-2003]). Liver IRI is a complex pathophysiological response that cannot be fully avoided during liver transplantation. Oxidative stress and inflammatory responses are the main mechanisms underlying liver damage during liver transplantation ([@b3-mmr-22-03-2003],[@b4-mmr-22-03-2003]). Donor organs with impaired function severely threaten the short- and long-term prognosis of the patient receiving the liver transplantation ([@b1-mmr-22-03-2003],[@b2-mmr-22-03-2003]); therefore, identifying strategies that focus on reducing liver IRI and preserving organ quality are of high importance.

At present, HMP and CS are the two most commonly used strategies for organ preservation ([@b34-mmr-22-03-2003]). Numerous studies have demonstrated that HMP preserves organs more effectively compared with CS ([@b7-mmr-22-03-2003]--[@b10-mmr-22-03-2003]). HMP, which can cause vascular shear stress by pumping perfusate, allows for organ optimization and offers a platform for viability assessment, organ repair and resuscitation ([@b35-mmr-22-03-2003],[@b36-mmr-22-03-2003]). Despite the extensive studies on HMP, the optimal perfusion time has not been reported and the molecular mechanisms underlying HMP are not completely understood. In the present study, a well-established animal model was used to generate DCD livers, which were then preserved by HMP or CS. Liver quality was assessed at six different time points (0, 1, 3, 5, 12 and 24 h). The results suggsted that HMP preserved DCD livers more effectively compared with CS, which was consistent with our previous studies ([@b6-mmr-22-03-2003],[@b10-mmr-22-03-2003],[@b13-mmr-22-03-2003]). In addition, morphological alterations to the liver tissues indicated that the protective effect of HMP was most notable at the 3 h timepoint.

Vascular shear stress serves an important role in the regulation of vascular function, while laminar shear stress mechanically stimulates vascular endothelium and induces the expression of flow-dependent vascular protective genes ([@b12-mmr-22-03-2003],[@b21-mmr-22-03-2003],[@b37-mmr-22-03-2003]). Moreover, laminar flow can activate a number of distinct signaling pathways in ECs to modulate transcription factor activity ([@b37-mmr-22-03-2003]), with the MEF2 transcription family being an example. MEF2 proteins are members of the MCM1 agamous-deficiens-serum response factor family of transcription factors, which bind to AT-rich sequences. There are four isoforms of MEF2: MEF2A, MEF2B, MEF2C and MEF2D ([@b38-mmr-22-03-2003]). MEF2C displays a key role during EC angiogenesis ([@b39-mmr-22-03-2003]), and Xu *et al* ([@b40-mmr-22-03-2003]) reported that MEF2C suppresses EC inflammation by regulating NF-κB and KLF2 expression. The most extensively studied *in vitro* targets of MEF2 in ECs are KLF2 and KLF4, which regulate antithrombotic and anti-inflammatory transcriptional signaling pathways ([@b41-mmr-22-03-2003]). Parmar *et al* ([@b42-mmr-22-03-2003]) demonstrated that overexpression of a dominant-negative MEF2 variant prevents flow-mediated induction of KLF2 expression in ECs. As an important flow-regulated molecule, KLF2 has greatly advanced the understanding of the molecular mechanisms underlying vascular homeostasis ([@b12-mmr-22-03-2003],[@b15-mmr-22-03-2003],[@b37-mmr-22-03-2003]). KLF2 interacts with NF-κB during the inflammatory immune response, which activates NF-κB and leads to nuclear translocation. In the nucleus, NF-κB regulates the expression of downstream inflammation factors, such as TNF-α and IL-1β, via the p65 subunit, which serves a critical role in kidney IRI ([@b43-mmr-22-03-2003],[@b44-mmr-22-03-2003]). In the present study, MEF2C and KLF2 expression levels were significantly increased, whereas NF-κB p65, IL-1β and TNF-α expression levels were significantly decreased in HMP livers compared with CS livers. The results suggested that KLF2/NF-κB-dependent inflammation was associated with the protective effects of HMP in DCD livers.

However, the differences between HMP and CS at the 1 h timepoint were not statistically significant, which may be explained by the fact that MEF2C and KLF2 are exclusively induced by laminar flow and not by disturbed flow ([@b37-mmr-22-03-2003],[@b42-mmr-22-03-2003]). Based on the present findings it was speculated that during perfusion, the perfusion flow is constant, but the vessels of the liver are flexible. At the beginning of perfusion, intrahepatic resistance may be relatively high due to thrombi, and the perfusion flow may not effectively eliminate toxic metabolites and provide adequate nutrients to the liver, thus inducing MEF2C and KLF2 expression. Therefore, sufficient perfusion times are required, and this requires further investigation. The present study indicated that the expression levels of MEF2C and KLF2 peaked after 3 h of HMP and then gradually reduced with increased perfusion duration. In addition, the levels of NF-κB p65, IL-1β, and TNF-α were lowest at 3 h compared with the other timepoints, which was consistent with the morphological alterations that were observed. A potential explanation for the aforementioned results is that 3 h of HMP is sufficient to achieve a steady laminar flow, allowing effective liver perfusion and significant induction of MEF2C and KLF2 expression. Nevertheless, no matter how effective HMP may be, it can only delay organ damage caused by cold ischemia ([@b35-mmr-22-03-2003]). With prolonged perfusion times, livers experienced edema, and because hepatic sinuses were not elastic, the intrahepatic resistance increased and the perfusion flow in liver sinuses decreased, which resulted in decreased MEF2C and KLF2 expression. Therefore, the results indicated that the optimal perfusion time for HMP to effectively inhibit inflammation was 3 h.

Based on the aforementioned results, the IPRL system was used to imitate transplantation and evaluate the protective effects of HMP. A significant reduction in ALT, AST and LDH levels was observed in HMP-perfused livers compared with CS-perfused livers at different reperfusion time points. Moreover, liver oxygen consumption was significantly higher in the HMP group compared with the CS groups. Bile production was also higher in the HMP group compared with the CS group, but the difference was not statistically significant, possibly because the liver was only perfused via the portal vein and not via the hepatic artery. The hepatic artery is the only source of blood supply to the bile duct; therefore, the biliary tract may not have received sufficient oxygen supply in the present study ([@b45-mmr-22-03-2003]). To elucidate the mechanisms underlying the protective effects of HMP, the expression levels of NF-κB and eNOS/NO signaling pathway-related proteins were measured. The NF-κB signaling pathway serves an important role during the inflammatory response ([@b16-mmr-22-03-2003],[@b40-mmr-22-03-2003]), and eNOS is the most important NOS isoform that constitutively produces NO under physiological conditions ([@b23-mmr-22-03-2003]). In ECs, the homeostasis of eNOS/NO displays an important role in oxidative stress and the process IRI ([@b25-mmr-22-03-2003],[@b46-mmr-22-03-2003]). The results of the present study indicated that HMP alleviated the inflammatory response and oxidative stress injury during IRI by inducing KLF2 expression, which inhibited NF-κB signaling and activated eNOS/NO signaling.

The present study had a number of limitations. The optimal perfusion time for DCD livers was determined by focusing only on KLF2 levels rather than the total gene expression profile. In addition, the *ex vivo* perfusion model used in the present study only allowed for a short observation period after reperfusion; therefore, long-term effects, including those of transplantation, were not assessed and require further investigation. Finally, the results were obtained using an *ex vivo* model that was perfused via the portal vein, so the effects of perfusion via the hepatic artery or both blood vessels were not examined.

The present study further suggested that HMP was more effective at preserving DCD livers compared with CS. The results indicated that the optimal perfusion time for HMP was 3 h, and that shorter or longer perfusion times did not achieve the desired perfusion effect. In addition, the protective effects of HMP were primarily exerted via attenuation of the KLF2/NF-κB/eNOS-dependent inflammatory response and oxidative stress.
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![HMP attenuates ischemia-induced hepatic pathological damage. (A) Hepatic tissue sections were stained with hematoxylin and eosin (magnification, ×200). (B) The degree of damage was graded using Suzuki\'s scoring system. \*P\<0.05 vs. CS; ^\#^P\>0.05 vs. CS. HMP, hypothermic machine perfusion; CS, cold storage; WI, warm ischemia.](MMR-22-03-2003-g00){#f1-mmr-22-03-2003}

![Expression levels of MEF2C, KLF2, NF-κB p65, TNF-α and IL-1β in liver tissues. Protein expression levels were (A) determined by western blotting and semi-quantified for (B) MEF2C, (C) KLF2 and (D) NF-κB p65. (E) TNF-α and (F) IL-1β expression levels were assessed by ELISA. \*P\<0.05 vs. CS; ^\#^P\>0.05 vs. CS. MEF2C, myocyte enhancer factor 2; KLF2, kruppel-like factor 2; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; CS, cold storage; HMP, hypothermic machine perfusion; WI, warm ischemia.](MMR-22-03-2003-g01){#f2-mmr-22-03-2003}

![Evaluation of hepatocellular injury after NR. Release of (A) ALT, (B) AST and (C) LDH during NR after 3 h of HMP or CS. (D) Oxygen consumption and (E) bile production during NR after 3 h of HMP or CS. \*P\<0.05 vs. CS; ^\#^P\>0.05 vs. CS. NR, normothermic reperfusion; ALT, alanine transaminase; AST, aspartate transaminase; LDH, lactate dehydrogenase; HMP, hypothermic machine perfusion; CS, cold storage.](MMR-22-03-2003-g02){#f3-mmr-22-03-2003}

![Expression levels of MEF2C, KLF2, NF-κB p65, TNF-α and IL-1β after NR. Protein expression levels were (A) determined by western blotting and semi-quantified for (B) MEF2C, (C) KLF2 and (D) NF-κB p65. Expression levels of the inflammatory cytokines (E) TNF-α and (F) IL-1β were measured by ELISA. \*P\<0.05 vs. CS. MEF2C, myocyte enhancer factor 2; KLF2, kruppel-like factor 2; TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; NR, normothermic reperfusion; CS, cold storage; HMP, hypothermic machine perfusion.](MMR-22-03-2003-g03){#f4-mmr-22-03-2003}

![Expression levels of eNOS, p-eNOS and NO after NR. Protein expression levels were (A) determined by western blotting and semi-quantified for (B) eNOS and (C) p-eNOS. (D) The ratio of total eNOS/p-eNOS. (E) NO levels in the perfusate. \*P\<0.05 vs. CS. eNOS, endothelial nitric oxide synthase; p, phosphorylated; NO, nitric oxide; NR, normothermic reperfusion; CS, cold storage; HMP, hypothermic machine perfusion.](MMR-22-03-2003-g04){#f5-mmr-22-03-2003}
